Imane Maiouet | Applied microbiology and biotechnology | Young Scientist Award

Ms. Imane Maiouet | Applied microbiology and biotechnology | Young Scientist Award

University Hassan 2 of Casablanca, Faculty of Sciences and Techniques Mohammedia | Morocco

Ms. Imane Maiouet research focuses on microbial biotechnology with a specialization in the isolation, technological characterization, antimicrobial profiling, and probiotic assessment of lactic acid bacteria (LAB) derived from dairy sources. Core investigations include phenotypic, biochemical, physiological, and molecular identification of LAB strains, followed by detailed evaluation of their fermentation behavior, acidification capacity, growth kinetics, and enzymatic activities. The work further explores antimicrobial mechanisms through agar diffusion assays, OD-based inhibition tests, and co-culture studies aimed at suppressing foodborne and clinical pathogens. A significant component involves identifying, purifying, and optimizing LAB-derived bioactive compounds, particularly bacteriocin-like substances, with potential applications in food safety and functional probiotics. Probiotic characterization includes assessing acid and bile tolerance, hydrophobicity, aggregation behavior, gastrointestinal resilience, enzymatic traits, and safety indicators such as hemolysis and antibiotic susceptibility. Additional studies address the technological performance of LAB in dairy environments, the impact of different processing conditions, and the development of strains with enhanced antagonistic and functional properties. Parallel research has examined biotechnological applications related to spoilage inhibition, environmental microbiology, and the integration of data analysis workflows using Python and statistical tools. Collectively, this work advances the development of beneficial LAB strains with promising industrial, probiotic, and biopreservative potential.

Featured Publication

Kiran Mawale | Agricultural and Biological Sciences | Young Scientist Award

Dr. Kiran Mawale | Agricultural and Biological Sciences
| Young Scientist Award

CSIR Central Food Technological Research Institute Mysore | India

Dr. Kiran Mawale’s research focuses on the development, characterization, and application of nanoparticles in plant systems, particularly in enhancing growth, metabolite production, and pest management in Capsicum species. His work integrates nanotechnology with plant biotechnology to explore the modulation of phenylpropanoid pathway metabolites and antioxidant responses using metallic, chitosan-based, and biogenic nanoparticles. He has systematically studied the phytostimulatory and biochemical impacts of nanoparticle formulations on in vitro and ex vitro chilli cultures, demonstrating significant improvements in plant growth, bioactive yield, and resistance to thrips infestation. His research extends to molecular biology through the differential expression analysis of genes associated with pungency and antioxidant activity. By employing advanced characterization techniques such as DLS, Zeta potential, FTIR, XRD, SEM, and TEM, he established structure–function relationships between nanoparticle properties and their biological effects. His interdisciplinary contributions encompass nanoscience, plant cell culture, and metabolite profiling, with a strong emphasis on sustainable, nano-enabled strategies for crop protection and quality enhancement. Collectively, his findings advance the field of agri-nanobiotechnology, offering eco-friendly approaches for improving plant health, productivity, and biochemical fortification.

Featured Publications

Mawale, K. S., Kaila, N. H. J., Halami, P. M., Ramakrishna, C., Singanahalli Shivaramu, M., & Serva Peddha, M. (2025, October 10). Physicochemical and functional characterization of pearl millet-based probiotic beverage for antiaging potential in Caenorhabditis elegans. Foods, 14(20), 3460. https://doi.org/10.3390/foods14203460

Raphel, S., & Halami, P. M. (2025, June). Bioactive compounds from food-grade Bacillus. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.13935

Goel, A., & Halami, P. M. (2024, September). Safety assessment of probiotic Lactiplantibacillus plantarum MCC5231 and its persistence in gastrointestinal tract. Microbial Pathogenesis, 186, 106824. https://doi.org/10.1016/j.micpath.2024.106824

Peerzade, I. J., Mutturi, S., & Halami, P. M. (2024, May). Improved production of RNA-inhibiting antimicrobial peptide by Bacillus licheniformis MCC 2514 facilitated by a genetic algorithm optimized medium. Bioprocess and Biosystems Engineering. https://doi.org/10.1007/s00449-024-02998-2

Goel, A., Chauhan, A. S., & Halami, P. M. (2023, December). Lactiplantibacillus plantarum MCC5231 enriched carrot (Daucus carota) nectar: A value-added beverage with enhanced vitamin A. Journal of Food Measurement and Characterization, 17(12), 10205–10216. https://doi.org/10.1007/s11694-023-02104-2

Archer, A. C., Muthukumar, S. P., & Halami, P. M. (2023, October). Correction to: Lactobacillus fermentum MCC2759 and MCC2760 alleviate inflammation and intestinal function in high-fat diet-fed and streptozotocin-induced diabetic rats. Probiotics and Antimicrobial Proteins, 15(5), 1271–1272. https://doi.org/10.1007/s12602-023-10122-1

ABDALLAH ALDAHOUK | Biomedical engineering | Best Researcher Award

Mr. ABDALLAH ALDAHOUK l Biomedical engineering
| Best Researcher Award

Istanbul University-Cerrahpaşa | State of Palestine

Mr. ABDALLAH ALDAHOUK , the research conducted focuses on the validation and application of Monte Carlo simulation techniques using GATE (Geant4 Application for Tomographic Emission) software for modeling computed tomography (CT) imaging systems. This work aims to enhance the accuracy and efficiency of CT imaging through advanced computational modeling, allowing precise evaluation of image quality parameters and radiation dose distribution. By employing the Catphan CTP404 phantom, the study investigates the reliability of simulated data in replicating clinical imaging conditions, ensuring that virtual simulations closely mirror real-world CT performance. The research contributes to the optimization of CT imaging protocols, reduction of patient radiation exposure, and improvement of diagnostic accuracy. It further explores the integration of simulation-based calibration and validation methods in biomedical imaging, providing a framework for developing next-generation imaging systems with enhanced resolution and safety. The findings demonstrate the potential of GATE-based Monte Carlo simulations as a powerful tool for medical physicists and biomedical engineers to design, assess, and refine imaging systems without the need for extensive experimental trials. This work represents a significant advancement in computational biomedical engineering, bridging theoretical modeling and clinical imaging applications for improved healthcare diagnostics and imaging innovation.

Profile:  Orcid 

Featured Publication

Aldahouk, A. W., Sezdi, M., & Demir, M. (2026, February). Validation of GATE-based Monte Carlo simulation for clinical CT imaging using the Catphan CTP404 phantom. Radiation Physics and Chemistry, 218, 113364. https://doi.org/10.1016/j.radphyschem.2025.113364

Kanishka Uthansingh | Biotechnology | Best Researcher Award

Dr. Kanishka Uthansingh | Biotechnology | Best Researcher Award

Kalinga Institute of Industrial Technology | India

Dr. Kanishka Uthansingh is a dedicated biotechnology researcher and educator specializing in molecular diagnostics, genetic studies, and cancer research. With a strong background in biotechnology and clinical research, he has contributed significantly to understanding genetic polymorphisms, gastrointestinal diseases, and biomarker development for cancer diagnosis. His academic journey reflects a commitment to advancing molecular biology, bioinformatics, and microbiology while integrating research findings into clinical applications. Dr. Uthansingh has held research and academic roles in leading institutions, contributing to the development of diagnostic centers, awareness programs, and innovative studies in oncology and infectious diseases. He is widely published in national and international journals and actively participates in academic collaborations, conferences, and workshops. Passionate about mentoring students, he has supervised dissertations and projects in biotechnology and nursing, shaping future researchers in biomedical sciences. His work demonstrates a strong combination of technical expertise, teaching acumen, and a commitment to translational research for public health improvement.

Profile

Google Scholar

Education 

Dr. Kanishka Uthansingh completed his foundational education in zoology and biotechnology before earning advanced degrees in biotechnology and research. He holds a master’s degree in biotechnology, where he explored microbial identification techniques and biostatistics, and later pursued a doctoral degree in biotechnology at Siksha O Anusandhan Deemed to be University. His doctoral research focused on identifying and characterizing genes linked to gastric cancer and developing diagnostic biomarkers, incorporating fields such as molecular biology, bioinformatics, nanobiotechnology, and biodiversity conservation. During his academic training, Dr. Uthansingh gained extensive knowledge in cellular and molecular biology, microbiology, and computational biology, along with hands-on expertise in research methodologies and molecular techniques. He also participated in specialized coursework in cancer genetics, drug design, and disease epidemiology, shaping his expertise in translational biomedical research. This strong academic foundation has supported his multidisciplinary contributions to oncology, clinical microbiology, and molecular genetics, preparing him for impactful roles in academia and advanced clinical research.

Experience 

Dr. Kanishka Uthansingh has held progressive roles in academia, research, and diagnostics, combining laboratory expertise with clinical applications. He currently serves as an Assistant Professor at a leading cancer research center, coordinating research activities in gastroenterology, oncology, and molecular sciences. Previously, he worked as a Research Associate and PhD scholar at Siksha O Anusandhan University, where he investigated genetic polymorphisms in cancer and infectious diseases. His earlier experience as a Research Assistant focused on hepatocellular carcinoma, gastrointestinal bleeding, and microbial infections. Alongside research, Dr. Uthansingh has demonstrated a passion for teaching, serving as a lecturer and guest faculty, supervising numerous dissertations, and contributing to curriculum development in biotechnology and medical laboratory technology. His expertise extends to managing clinical trials, securing grants, and overseeing departmental publications. With experience in molecular diagnostics, genetic testing, and drug design, he bridges research and healthcare applications, fostering innovation while mentoring aspiring scientists and healthcare professionals.

Awards and Honors 

Dr. Kanishka Uthansingh has been recognized for his contributions to biomedical research and education through prestigious accolades. He was honored as a Member of the National Academy of Medical Sciences, a recognition of his research excellence in genetics and cancer biology. He qualified for competitive programs such as the Biotech Consortium India Limited industrial internship, which enhanced his technical and research expertise. His academic achievements also include qualifying national entrance examinations for medical and pharmacy programs, demonstrating early academic excellence. In addition to formal awards, Dr. Uthansingh has contributed significantly to scientific communities by publishing impactful research, authoring book chapters, and presenting at conferences. He has played a key role in establishing diagnostic research centers, developing awareness initiatives, and implementing hepatitis screening and immunization programs in underserved communities. His recognition reflects not only his academic accomplishments but also his leadership in advancing research and improving healthcare accessibility through scientific innovation.

Research Focus 

Dr. Kanishka Uthansingh’s research is rooted in molecular diagnostics, cancer genetics, and infectious disease studies. His work primarily focuses on identifying genetic polymorphisms associated with gastric cancer, colorectal cancer, and other gastrointestinal disorders, aiming to develop biomarkers for early disease detection. He has conducted extensive studies on gene mutations, antibiotic resistance patterns, and the molecular mechanisms driving cancer progression. In addition, his expertise extends to hepatocellular carcinoma, chronic pancreatitis, and the interplay of genetic and microbial factors in disease outcomes. Dr. Uthansingh has explored drug discovery through molecular docking, advancing targeted therapeutic strategies against pathogens like Helicobacter pylori. His interdisciplinary approach integrates molecular biology, microbiology, bioinformatics, and epidemiology to address pressing healthcare challenges. Beyond laboratory research, he emphasizes clinical applications, collaborating with healthcare teams to translate findings into diagnostics and treatments. His scholarly output, including journal publications, reviews, and book chapters, highlights his dedication to bridging research and clinical innovation.

Publications

Title: Hepatocellular carcinoma treatment: hurdles, advances and prospects
Year: 2018
Citations: 116

Title: Abdominal tuberculosis in Indians: still very pertinent
Year: 2019
Citations: 41

Title: The molecular connection of histopathological heterogeneity in hepatocellular carcinoma: A role of Wnt and Hedgehog signaling pathways
Year: 2018
Citations: 22

Title: Irritable bowel syndrome and the menstrual cycle
Year: 2021
Citations: 21

Title: Fatty changes associated with N-Nitrosodiethylamine (DEN) induced hepatocellular carcinoma: a role of sonic hedgehog signaling pathway
Year: 2020
Citations: 11

Conclusion

Dr. Kanishka Uthansingh is a highly promising and impactful biomedical researcher with notable contributions to cancer genomics, molecular diagnostics, and public health initiatives. His scholarly achievements, active clinical collaborations, and dedication to advancing biotechnology make him a strong candidate for the Best Researcher Award. With continued emphasis on high-impact publications, global collaborations, and translational outcomes, he has the potential to emerge as a leading figure in cancer research and molecular biotechnology.